Menu
We are a strategic marketing advisory firm focusing on pharmaceuticals, bio-pharmaceuticals, and vaccines. We are equipped to undertake any kind of strategic marketing initiative dealing with the Indian business landscape. We take pride in facilitating access to the Indian Life Sciences sector in a single straight-line method which includes the regulatory landscape as well. Our proprietary databases harness the power of Information Technology to its optimum capacity for business analytics yielding cost-effective solutions.
“STRATEGM forever strives to meet the unmet”
STRATEGM is a strategic marketing advisory firm focusing on life sciences, medical devices, and biomaterials. We effectively leverage the power of CI (Competitor Intelligence) and advanced digital technologies in tandem with our networked resources to deliver an action plan in consonance with the client's business objectives.
We are equipped to undertake any kind of strategic marketing initiative dealing with the Indian business landscape. We are eminently suited to collaborate on projects with our overseas clients while offering sound strategic advice to our clients from India. We believe in applying real-world insights to the tasks at hand for productive recommendations.
We empathize with our client's felt need to work out solutions on the premise of "joint ownership" of the task at hand. The power of IT is leveraged optimally to yield cost-effective solutions. We believe in applying the accumulated business expertise of the team over several decades to deliver business values.
A startup needs to frame a strategy plan that will serve as a roadmap towards commercial success. It requires incorporation of key metrics and parameters for translation of ideas to reality. Additionally it also serves to indicate to the investor community a clear plan to commercialization. Besides startups, established companies sometimes wish to diversify into an unrelated segment and seek to know the opportunities available. These studies are at an corporate overview to judge the feasibility of commercial success. We can help in resolution of uncertainties.
Profiling at Product development stage is a strong risk mitigation tool along with a great competitive advantage approach. Profiling an idea (product or service) helps to plan strategically. It is essential to know the Regulatory pathway, IP roadblocks and the Clinical validations required to facilitate commercial launch. This is essentially a product centric approach with the objective of deriving a clear understanding of the landscape to obtain clinically relevant labeling indications. The clinical trials themselves can be utilized as a strategy for competitive advantage. We have the relevant competence and the experience to assist you.
Prelaunch scan is an extension to the Product profiling study. While product development is in process, Companies remain focused on technical development, little realizing the importance of competitive positioning in the market place until it is too late into the day. This is a techno-commercial study to strengthen the Value proposition of the product and evolve a knock out set of product characteristics. It is a rigorous approach to the impending brand launch. Our longstanding association with the startup ecosystem gives us a wealth of experience.
New Product Launches are the means to a sustainable business growth. A successful launch demands a proactive approach to the unmet and latent needs of the market segment. Market Understanding is different from Market planning. That can partially explain the significant chunk of market failure for the innovative and unique products in the life science space. A whole gamut of planning is required to script success. Experienced hands with years of market insights and client focused mindsets might just save the day. We have scripted local going global and reverse engineered it too.
New Product Launches are the means to a sustainable business growth. A successful launch demands a proactive approach to the unmet and latent needs of the market segment. Market Understanding is different from Market planning. That can partially explain the significant chunk of market failure for the innovative and unique products in the life science space. A whole gamut of planning is required to script success. Experienced hands with years of market insights and client focused mindsets might just save the day. We have scripted local going global and reverse engineered it too.
Numerous Startups and SMEs have Innovation as the central business aspiration rather than commercialization of the technology or product invented. Going forward, the path to the market is seen to be expensive, risky and highly competitive. The risk mitigation measures are chiefly driven by effective strategic management processes and approaches. Professional brand management during the launch phase correctly delivers the value propositions to a targeted segment of consumers who connect with the brand attributes and generate the brand equity. Unfortunately less than 5% of the Patents reach the market and even if they do, face a mortality in excess of 70%. We have professional expertise and requisite intellectual resources to help tide over the critical phase of Market Launch.
Credibility in business warrants global certifications such as ISO, IEC, CE while Indian markets call for BIS compliance. Certifications go hand in hand with regulatory compliances and we are fully equipped to handle such requirements from our clients. The concurrent implementation of certifications during pre-commercialization phase adds to the punch during product roll outs. In certain cases like Medical devices, ISO 13485 is a necessary requirement and we strive to offer a single window service to our clients. We have inhouse certified resources for ISO 13485 implementation even for companies not having any QMS.
Life cycle assessment studies pave the way for renewal strategies at the therapy and brand levels. Based on the overall category prescription trends it is advisable to proactively plan for marketing interventions at late-growth, maturity and decline phases. Timing is of essence and it is seen that the benefits largely accrue to the early mover. Our expertise at decoding the prescription trends drawn from SMRC data (India) gives us an edge in conduct of such studies. We are also equipped to suggest Prescription to OTC switch depending on regulatory landscape and the business horizon.
Market leadership is a function of market share. In a competitive market place each day poses a challenge to the leader as well as the follower. Garnering market share is dependent on competitor intelligence. Benchmarking the addressable leader in the category will serve to engineer a creative differentiation for quick penetration and early diffusion of message. The market leader is chosen on dual criteria- by prescription share and market share. Our cutting edge experience in Indian markets in the life sciences sector posit us well for undertaking such studies.
The echoes of the global trends are being felt in the Indian business landscape. With the increase in number of field force and the “me-too” brands proliferating exponentially it is time to gauge the ROI on sale force effectiveness. This study can pick up critical disconnects and helps in formulating an integrative approach to long term relationship with the physicians. Customer Relationships is fortified with an effective sales force who should be energized with a scientific messaging approach rather than a discounts mindset. Pilot studies in any geographical location would toss up the pointers and the areas of improvement required to bring in higher revenue generation effectiveness.
It is well ingrained in the annals of Life sciences marketing that niche products thrive on recommendations by KOLs for rapid take-off. It is also a proven fact that irrespective of the therapeutic segment, prudent identification of KOL can give a critical impetus to the prospects of a brand at any given stage of Product Life Cycle. For a startup looking to foster credibility, institutionalization of a scientific advisory board with KOLs after due profiling adds to the company’s valuation. This also helps with product development being aligned with the unmet clinical needs that can be best articulated with practicing physicians. Our strong networking among the physician fraternity in India equips us to deliver up to expectations.
SMEs engaged in specialty pharma products often find a deterrent in engaging a highly skilled brand management resource chiefly on monetary considerations. With a view to address this vexing issue, an innovative service offering has been conceptualized, perhaps for the first time in India, where professional assistance is available at the fraction of the cost of a regular team. We can help by bringing world-class, customer-focused processes to your organization and ensure capability building and scale up to a truly brand building oriented organization. Options are available to manage your entire portfolio or a few select brands without disturbing your existing organizational equilibrium.
Get in Touch with us for a discussion, should you find this interesting!
Strategm Advisory Services
Address:
205, Gharonda Mahima Apartments, Padmarao Nagar, Secunderabad-500025